Botswana Vaccines Import Market -- HS Code 3002 Trade Data & Price Trend (Apr 2025)

Botswana Vaccines Import (HS 3002) Key Takeaways

Botswana's vaccines import under HS code 3002 in April 2025 reveals a market split between high-value immunological products and bulk veterinary vaccines, with premium retail items driving over 50% of import value despite minimal volume. The trade is highly volatile, with March 2025 peaking at $3.86 million before a sharp April pullback, likely due to tariff policy shifts. Supplier concentration is extreme, with a single group controlling 97% of import value, creating significant supply chain risk. Geographically, South Africa dominates volume as a regional hub, while Ireland leads in high-value shipments. This analysis is based on cleanly processed Customs data from the yTrade database for April 2025.

Botswana Vaccines Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood, vaccines, toxins, and cultures, with vaccines being a critical component for public health and livestock management. This category supports Botswana's healthcare and agricultural sectors, where vaccines are essential for disease prevention and biosecurity. Global demand remains stable due to ongoing health initiatives and the need for animal disease control.

Current Context and Strategic Position

Botswana's vaccines import market is influenced by regional trade agreements, including annual tariff rate quotas for MERCOSUR Member States as outlined in the [BURS tariff notes 2025]. This policy framework underscores the importance of monitoring trade flows to ensure compliance and cost efficiency. Botswana's reliance on imported vaccines highlights its strategic position in maintaining health security, making hs code 3002 trade data vital for market vigilance. Tracking Botswana's vaccines import trends is essential to anticipate supply chain disruptions and optimize procurement strategies.

Botswana Vaccines Import (HS 3002) Price Trend

Key Observations

In April 2025, Botswana's vaccine imports under HS code 3002 reached $1.32 million USD at a unit price of $91.36 per kg, reflecting a sharp pullback from March's elevated levels but remaining above the subdued activity seen in January and February. This Botswana Vaccines Import trend indicates heightened volatility, with April's value down sequentially yet still contributing to a robust first-quarter performance overall.

Price and Volume Dynamics

The hs code 3002 value trend exhibited significant swings, climbing from $855,840 USD in January to a peak of $3.86 million USD in March before retreating in April. This volatility aligns with the implementation of new tariff rate quotas for MERCOSUR origins, as detailed in the [BURS] policy effective January 2025, which likely prompted importers to accelerate purchases early in the year to mitigate cost impacts. The sequential drop in April suggests a normalization after anticipatory buying, typical in vaccine markets where procurement cycles react to policy shifts and inventory replenishment needs.

Botswana Vaccines Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

According to yTrade data, Botswana's import of HS Code 3002 in April 2025 is highly specialized, dominated by high-value immunological products in retail packaging (sub-code 30021500), which represents over 50% of the total import value despite a minimal 1.3% quantity share. This sub-code commands a unit price of approximately 1,381 USD per unit, far exceeding other products, indicating a focus on premium, finished goods. The analysis isolates minor entries like human medicine vaccines and other toxins due to their negligible impact.

Value-Chain Structure and Grade Analysis

The import structure under HS Code 3002 for Botswana reveals three distinct product tiers: high-value retail immunological goods, bulk veterinary vaccines with low unit prices (around 14 USD per unit), and intermediate blood fractions at moderate prices. This diversity suggests a market for differentiated manufactured products rather than fungible commodities, with veterinary vaccines dominating volume but not value. HS Code 3002 trade data shows a clear split between mass-market and specialized healthcare items.

Strategic Implication and Pricing Power

For importers, the high unit prices of retail immunological products imply strong pricing power for suppliers of these goods, while bulk veterinary vaccines face more competitive pressures. Strategic focus should prioritize securing reliable sources for high-value items to maximize returns, given Botswana's import profile under HS Code 3002. This structure favors suppliers with diversified offerings to cater to both volume and premium segments.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Vaccines Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

Botswana's vaccine imports in April 2025 show a clear split between a dominant volume supplier and a high-value partner. South Africa is the overwhelming volume leader, responsible for 81.93% of the quantity and 91.72% of the weight. However, Ireland is the top partner by import value, accounting for 48.62% of the total. This disparity, where Ireland's value share is massively higher than its quantity share, points to Botswana sourcing high-value, finished vaccines from there. South Africa's role is primarily logistical, acting as a bulk supplier or regional distribution hub for these imports.

Origin Countries Clusters and Underlying Causes

The import partners form three clear groups. The High-Yield Cluster includes Ireland, the United Kingdom, Israel, India, and Switzerland. These countries have high value shares relative to their low shipment volumes, indicating they supply premium, finished vaccines. The Volume/Hub Cluster consists of South Africa, the Netherlands, and Spain. They ship large quantities but at lower average values, reinforcing South Africa's role as a key transshipment point for vaccines entering the region. The Transactional Cluster includes the United States and Germany, characterized by a high number of shipments (frequency) but low total volume and value, suggesting smaller, more frequent orders of specialized products.

Forward Strategy and Supply Chain Implications

Botswana's vaccine supply chain is heavily reliant on South Africa for volume and Ireland for high-value products. This creates a strategic dependency on South African logistics and infrastructure for the majority of shipments. To ensure stability, Botswana should consider deepening relationships with other high-value European suppliers to mitigate any risk of disruption from its primary partners. Maintaining this dual sourcing strategy from both a regional hub and direct premium producers is crucial for a secure and diverse vaccine supply.

Table: Botswana Vaccines (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Vaccines (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

According to yTrade data, the Botswana vaccines import suppliers market in April 2025 was highly concentrated. A single group of suppliers, responsible for over 97% of the total import value, dominated trade. This group also handled the vast majority of shipment frequency and volume, making them the core of the supply chain. The typical trade involved large, frequent shipments from a very small number of key partners.

Strategic Supplier Clusters and Trade Role

The profile of the dominant HS code 3002 suppliers, including companies like KYRON and MEDPET PTY LTD, points to a direct-to-factory sourcing model. These appear to be primary manufacturers or major distributors, not trading intermediaries. A smaller, secondary cluster of suppliers accounted for a minor share of value through more frequent, lower-value shipments. This structure shows a market reliant on a tight group of principal partners for the bulk of supply.

Sourcing Strategy and Vulnerability

Botswana's heavy reliance on a narrow supplier base for vaccines creates a significant vulnerability to supply chain disruptions. The strategic focus must be on developing alternative sources to mitigate this concentration risk. This need is underscored by external trade policy developments, such as the tariff rate quotas for goods from MERCOSUR Member States detailed in the [BURS] document, which could influence future sourcing costs and strategies. Diversifying import partners is a critical next step.

Table: Botswana Vaccines (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Vaccines Supplier lists

Action Plan for Vaccines Market Operation and Expansion

• Use hs code 3002 trade data to diversify supplier partnerships beyond the dominant few, reducing reliance and enhancing resilience in Botswana's Vaccines Import supply chain against disruptions.
• Prioritize procurement of high-value immunological products identified in hs code 3002 trade data to capitalize on strong pricing power and maximize returns for Botswana's Vaccines Import.
• Expand sourcing to other high-yield European countries using trade data insights, diversifying the Vaccines supply chain to lessen dependency on primary partners like Ireland.
• Monitor trade policy changes and hs code 3002 trends regularly to adapt sourcing strategies, safeguarding Botswana's Vaccines Import from cost spikes and ensuring continuity.
• Leverage shipment frequency data from key suppliers to optimize inventory levels, preventing overstock and ensuring efficient flow in the Vaccines supply chain for timely availability.

Take Action Now —— Explore Botswana Vaccines Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Vaccines Import 2025 April?

The April 2025 import value of $1.32 million USD reflects a sharp decline from March's peak, likely due to anticipatory buying earlier in the year to mitigate tariff changes. Volatility stems from policy shifts like MERCOSUR tariff rate quotas, creating cyclical procurement patterns.

Q2. Who are the main origin countries of Botswana Vaccines (HS Code 3002) 2025 April?

Ireland (48.62% of value) and South Africa (81.93% of quantity) dominate, with Ireland supplying high-value finished vaccines and South Africa serving as a bulk logistics hub. The UK, Israel, and India form a secondary high-yield cluster.

Q3. Why does the unit price differ across origin countries of Botswana Vaccines Import?

Price gaps arise from product specialization: Ireland's retail immunological products (sub-code 30021500) command ~1,381 USD per unit, while South Africa's bulk veterinary vaccines average 14 USD per unit, reflecting premium vs. volume segments.

Q4. What should importers in Botswana focus on when buying Vaccines?

Importers must prioritize securing high-value immunological products from reliable suppliers like KYRON while diversifying away from over-reliance on South Africa for bulk shipments to mitigate supply chain risks.

Q5. What does this Botswana Vaccines import pattern mean for overseas suppliers?

Suppliers of premium finished vaccines (e.g., Irish, UK firms) hold pricing power, while bulk producers face competitive pressure. Botswana's dual sourcing strategy favors suppliers with differentiated offerings for both premium and volume segments.

Q6. How is Vaccines typically used in this trade flow?

Imports under HS Code 3002 serve Botswana's healthcare needs, split between high-value human immunological products for retail use and bulk veterinary vaccines for agricultural applications, reflecting a dual demand structure.